The choice of general anesthetic regimen—either total intravenous anesthesia (TIVA) or volatile anesthesia—does not appear to affect cancer outcomes after…
Browsing: Hot headlines in GI
Inflammatory bowel diseases (IBDs), including Crohn’s disease and ulcerative colitis, are chronic, progressive, immune-mediated diseases of adults and children that…
In May 2021, the Centers for Medicare and Medicaid Services (CMS) Quality Measures Voting Members unanimously recommended the addition of…
Scrubs & Heels, a new initiative created by women for women in the field of gastroenterology, aims to empower women…
Medical device and technology company Lazurite Holdings LLC has been recognized by MedTech Outlook magazine as a 2021 Top 10…
Results from a double-blind, randomized OPT-PEACE trial showed that almost all patients (at low bleeding risk) who received antiplatelet therapy…
According to the hospital, the most effective treatment for metastatic colorectal cancer is targeted therapy and chemotherapy, which block only…
By Landon Gray Originally published in our sister publication, Gastroenterology & Endoscopy News Phathom announced the FDA approval of vonoprazan tablets, amoxicillin capsules, clarithromycin tablets (Voquezna Triple PAK, Phathom)…
A complaint filed with the U.S. Department of Justice (DOJ) alleges that Alabama’s Medicaid program is illegally denying curative drug…
Applications are now open for the 2023 AGA Fellowship cohort. AGA is proud to formally recognize its exemplary members whose accomplishments and contributions…